Monday, May 21, 2012

  • The Definitive Biotech ETF Guide (IBB, XBI, FBT) (ABT, AFFY, AMGN, AMLN, Analyst Color, BBH, CBST, CELG, FBT, GILD, IBB, INCY, Long Ideas, News, PBE, PFE, PJP, PSCH, QCOR, Sector ETFs, SLXP, VRTX, XBI, Short Ideas, Rumors, Small Cap Analysis, FDA, M&A, Events, Intraday Update, Markets, Analyst Ratings, Movers, Trading Ideas, ETFs / Mon, 01:35pm)

Wednesday, May 16, 2012

  • J.P. Morgan Reiterates Overweight Rating, $65 PT for Gilead Sciences (Analyst Color, GILD, Reiteration, Analyst Ratings / Wed, 12:12pm)

Tuesday, May 15, 2012

  • S&P Bullish On Biotech ETFs (FBT, IBB, XBI) (ABT, AFFY, AMGN, AMLN, Analyst Color, FBT, GILD, IBB, INCY, Long Ideas, MRK, News, PFE, PJP, Sector ETFs, VRTX, XBI, Short Ideas, Rumors, FDA, M&A, Intraday Update, Markets, Analyst Ratings, Trading Ideas, ETFs / Tue, 02:31pm)

Thursday, April 19, 2012

  • Financial Breakfast: Morning News Summary for April 19, 2012 (BAC, Bonds, CHK, CVI, DD, Earnings, EBAY, FFIV, GILD, GSK, HGSI, LUV, MS, News, PM, Futures, Guidance, Upgrades, Commodities, Downgrades, Forex, Technicals, FDA, M&A, Events, Global, Economics, Pre-Market Outlook, Markets, Analyst Ratings, Trading Ideas, General / Thu, 07:38am)

Tuesday, April 03, 2012

  • Brean Murray Carret Discusses Gilead's Potential Competitor (Analyst Color, GILD, GSK, Reiteration, Analyst Ratings / Tue, 09:09am)

Thursday, March 15, 2012

  • UPDATE: Stifel Nicolaus Resumes Buy, $57 PT on Gilead Sciences (Analyst Color, GILD, Price Target, Initiation, Intraday Update, Analyst Ratings / Thu, 11:43am)

Wednesday, March 07, 2012

  • Morgan Stanley Updates Gilead Sciences Model (Analyst Color, GILD, Reiteration, Analyst Ratings / Wed, 10:26am)

Monday, February 27, 2012

  • Deutsche Bank Reiterates Buy, $57 PT on Gilead Sciences (Analyst Color, GILD, Price Target, Reiteration, Intraday Update, Analyst Ratings / Mon, 10:48am)
  • Morgan Stanley: 7977 Will Be Vital in All-Oral HCV Therapy (Analyst Color, GILD, Reiteration, Analyst Ratings / Mon, 10:06am)

Friday, February 24, 2012

  • UPDATE: Deutsche Bank Cuts Target to $57 on Gilead Sciences (Analyst Color, GILD, Price Target, Reiteration, Intraday Update, Analyst Ratings / Fri, 11:29am)

Thursday, February 23, 2012

  • JP Morgan Remains Bullish on Gilead Sciences (Analyst Color, GILD, Reiteration, Analyst Ratings / Thu, 11:30am)

Friday, February 17, 2012

  • Gilead Falls On Disappointing Hep C Drug Data; Analysts Remain Bullish (ACHN, Analyst Color, BMY, C, GILD, IDIX, JPM, News, VRTX, Small Cap, FDA, Events, Intraday Update, Analyst Ratings, Movers / Fri, 01:30pm)
  • Gilead Sciences Negative Data Ripples through Biotech Field, Boosting Vertex, Achillion; Knocking Idenix (ACHN, Analyst Color, GILD, IDIX, News, VRTX, FDA, Pre-Market Outlook, Analyst Ratings, Movers / Fri, 08:54am)
  • Deutsche Bank Sees Buying Opportunity on Gilead Share Weakess (Analyst Color, GILD, Reiteration, Pre-Market Outlook, Analyst Ratings / Fri, 08:41am)

Friday, February 10, 2012

  • Morgan Stanley Initiates Coverage on Gilead Sciences at Overweight, Announces PT of $65 (GILD, Price Target, Initiation, Analyst Ratings / Fri, 07:41am)

Friday, February 03, 2012

  • Gilead Sciences Soars On "Striking" Clinical Trial Data (Analyst Color, Earnings, GILD, JPM, Long Ideas, News, Guidance, Short Ideas, Price Target, FDA, Intraday Update, Markets, Analyst Ratings, Movers, Trading Ideas / Fri, 02:33pm)
  • UPDATE: JP Morgan Raises Target to $65 on Gilead Sciences (Analyst Color, GILD, Price Target, Reiteration, Intraday Update, Analyst Ratings / Fri, 10:36am)
  • Brean Murray Maintains Sell on Idenix (GILD, IDIX, Reiteration, Pre-Market Outlook, Analyst Ratings / Fri, 10:02am)
  • UPDATE: Deutsche Bank Raises Target to $66 on Gilead Sciences (Analyst Color, GILD, Price Target, Reiteration, Pre-Market Outlook, Analyst Ratings / Fri, 08:13am)
  • JP Morgan Raises PT on Gilead Sciences to $65 (GILD, Price Target, Pre-Market Outlook, Analyst Ratings / Fri, 07:59am)

Thursday, January 26, 2012

  • Brean Murray Carret & Co. Raises Gilead Sciences PT To $60 (Analyst Color, GILD, Price Target, Analyst Ratings / Thu, 05:00pm)

Tuesday, January 10, 2012

  • Going Nuc-lear on Hepatitis C -- Is Idenix the Next Target? (ABT, ACHN, BMY, GILD, IDIX, INHX, JNJ, Long Ideas, MRK, News, NVS, PFE, VRTX, VRUS, Short Ideas, Price Target, Rumors, M&A, Events, Intraday Update, Analyst Ratings, Movers, Trading Ideas / Tue, 03:54pm)

Wednesday, December 28, 2011

  • Citigroup Reiterates Buy, $49 Target on Gilead Sciences (GILD, Reiteration, Pre-Market Outlook, Markets, Analyst Ratings / Wed, 08:09am)

Tuesday, December 27, 2011

  • Citigroup Reiterates Buy, $49 Target on Gilead Sciences (GILD, Reiteration, Intraday Update, Markets, Analyst Ratings / Tue, 11:34am)

Friday, December 16, 2011

  • Wedbush Securities Drops Coverage on Pharmasset on Pending Gilead Acquisition (GILD, VRUS, After-Hours Center, Analyst Ratings / Fri, 05:24pm)
  • JP Morgan Overweight on Gilead Sciences After Pharmasset QUANTUM Trial Announcement (Analyst Color, GILD, VRUS, Reiteration, Analyst Ratings / Fri, 10:50am)

Wednesday, December 07, 2011

  • Financial Breakfast: Morning News Summary for December 7, 2011 (CBAK, DG, DUK, Earnings, GILD, JCP, MSO, News, PEG, REN, SMG, Futures, Upgrades, Commodities, Downgrades, Financing, Forex, Technicals, Offerings, M&A, Events, Global, Econ #s, Economics, Pre-Market Outlook, Markets, Analyst Ratings, Trading Ideas, General / Wed, 08:26am)

Monday, December 05, 2011

  • Deutsche Bank Reiterates Buy, $53 PT on Gilead (Analyst Color, GILD, News, Reiteration, FDA, Intraday Update, Markets, Analyst Ratings, Movers / Mon, 01:16pm)
  • Citi Reiterates Buy, $49 PT on Gilead (Analyst Color, GILD, News, VRUS, Price Target, Reiteration, FDA, Intraday Update, Markets, Analyst Ratings, Movers, Trading Ideas / Mon, 01:11pm)
  • J.P. Morgan Reiterates Overweight On Gilead (Analyst Color, GILD, News, VRUS, Reiteration, FDA, Intraday Update, Markets, Analyst Ratings, Movers, Trading Ideas / Mon, 01:07pm)

Tuesday, November 29, 2011

  • Brean Murray Raises Inhibitex PT to $19 From $12 (Analyst Color, GILD, INHX, Long Ideas, News, VRUS, Price Target, Reiteration, FDA, Intraday Update, Markets, Analyst Ratings, Trading Ideas / Tue, 01:25pm)

Monday, November 28, 2011

  • Deutsche Bank Has Buy, $53 PT On Gilead (Analyst Color, GILD, News, VRUS, Price Target, Reiteration, FDA, M&A, Intraday Update, Markets, Analyst Ratings, Trading Ideas / Mon, 12:37pm)
  • Goldman Sachs Adds Gilead Sciences to Conviction Buy List (GILD, Upgrades, Pre-Market Outlook, Analyst Ratings / Mon, 08:11am)

Wednesday, November 23, 2011

  • Argus Downgrades Gilead Sciences to Hold (GILD, Downgrades, Pre-Market Outlook, Analyst Ratings / Wed, 08:46am)

Tuesday, November 22, 2011

  • Brean Murray Downgrades Pharmasset to "Hold" (Analyst Color, GILD, News, VRUS, Downgrades, Price Target, FDA, M&A, Intraday Update, Markets, Analyst Ratings, Movers, Trading Ideas / Tue, 12:29pm)
  • UPDATE: Bank of America Upgrades Gilead Sciences to Buy (Analyst Color, GILD, News, Upgrades, Price Target, M&A, Analyst Ratings / Tue, 10:52am)
  • next ›